Eisai to Present Latest Data on Lemborexant at SLEEP 2023
Tokyo-based Eisai will present eight poster presentations on its orexin receptor antagonist lemborexant (Dayvigo) at SLEEP 2023.
Source: sleepreviewmag.com
Stay updated with breaking news from Daytime Functioning Items. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Tokyo-based Eisai will present eight poster presentations on its orexin receptor antagonist lemborexant (Dayvigo) at SLEEP 2023.